PDL members are kept notified via our regular email notices called Practice Alerts. We bring awareness to potential risks that could impede on the pharmacy profession. They are often sent reactively, from trends and incident reports conducted by PDL and other influencing bodies, in a bid to help our members avoid an incident. They can be national alerts or state-specific if connected to local legislation.
A wide range of guides and resources are also available to PDL members that have been developed to support pharmacists in their daily practice.
Pharmacists are at the forefront of patient care, ensuring the safe and effective use of medications. Despite pharmacists best efforts, incidents can result in complaints, even if there is minimal impact on the patient and immediate resolution has occurred. This
PDL Professional Officers occasionally receive incident reports and notifications relating to breaches or concerns regarding access to a patient’s My Health Record. Some of these cases require responses to the Australian Digital Health Agency (ADHA) and/or the Office of the
PDL Professional Officers continue to receive enquiries and incident reports that have contributing factors such as pressure, stress, workload or fatigue. PDL recognises the high demands placed on community and hospital pharmacists including interns, pharmacy owners and other staff members
Meridian Lawyers issue state and territory-specific guides It’s OK to say sorry. Pharmacists are human beings and fallible, so despite their best efforts, adverse events and mistakes can still occur. A key component of managing an incident is offering a
Meridian Lawyers has collaborated with PDL to prepare an article about professional boundaries and the types of conduct that are likely to be the subject of complaint to regulators. The article...
Every year, PDL receives calls from pharmacists who have overlooked their Pharmacy Board of Australia (PBA) registration renewal. This may happen due to renewal reminders being quarantined in junk or...
The prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia. With this emerging field comes the need for comprehensive risk management considerations and...
Off-label prescribing occurs when a medication is used for a purpose that is not approved by the Australian Therapeutic Goods Administration (TGA). It may involve using a medication in a different...
In recent weeks, the PDL Professional Officers have received a number of queries regarding pharmacists’ obligations and liability when dispensing Mounjaro® (tirzepatide). Tirzepatide is a...
Pharmacists have limited time left to register their interest in their pharmacy taking part in the NSW Pharmacy Trial, with the expression of interest process scheduled to close at 5pm on 15 November...
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.